horse race!this has been a long and exhausting horse race. right now we 'broke in the stretch' but know with irons in the fire we have regained our stride and is close to winning the race-mcna FDA approval!
As mentioned before, we have lots of cash...and will show on the balance sheet between 60-70 cents a share-next February......even if we don't get FDA approval...there are countries who will go ahead and endorse Urocidin. There is also a chance of being bought out-I would say between 1.50 and 2.50 a share...but what would be perfect is a bidding war...which would put this stock out of sight(100.00 maybe). 24 cents is ridiculously low. Buy and accumulate...it won't be there much longer IMHO good luck to all longtimers